Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme
Class ITerminatedD-809-2013

Drug recall · July 31, 2013

Mitosol recall

Why: Non-Sterility: one or more components of the kit have been found to be contaminated with yeast.

Class I: a reasonable chance the product could cause serious harm or death.

The recall

Product

Mitosol (mitomycin for solution), 0.2 mg/vial, Kit for Ophthalmic Use (NDC 49771-002-01), 3 kits per box (NDC 49771-002-03), Rx only, Manufactured for: Mobius Therapeutics, LLC, 4041 Forest Park Avenue, St. Louis, MO 63108 USA.

Lots / codes

Lot #: M086920 and M098260, Exp. 08/2013

Quantity
83 boxes
Company
Mobius Therapeutics LLC, Saint Louis, MO
Distribution
Nationwide and Military and Government Consignees
Initiated
January 3, 2013 · Voluntary: Firm initiated
Classified
July 19, 2013
Reported
July 31, 2013
Ended
July 29, 2013
How notified
Telephone

The drug: prices, other makers, shortages

If you have this product

  1. Check the lot number on your package against the lots above. Only those lots are recalled.
  2. Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
  3. Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
  4. Return or dispose of recalled product as the company or your pharmacy advises.

Questions about this recall

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Watch Mitomycin

One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.